The mission ofthe neuroimaging core is to facilitate funcfional and structural neuroimaging by ADRC investigators, to develop and maintain a neuroimaging database and to educate investigators on the potential of structural/functional neuroimaging in AD research.
The specific aims are: (1) Provide imaging data acquisition and processing for ADRC Project 1: The Course of Cognitive Change in Late Adulthood (Zelinski) and Project 3: Mild Cognitive Impairment in a Chinese- American Community (Zheng). (2) Provide technical support to investigators for pilot neuroimaging studies on a wide range of topics covering structural imaging, arterial spin-labeled (ASL) perfusion imaging, diffusion tensor imaging (DTI), funcfional magnefic resonance imaging (fMRI), voxel-based image analysis, and multimodality image co-registrafion. (3) Implement a web-based imaging database to archive and retrieve neuroimages and associated information acquired by ADRC investigators at USC and related sites, and (4) facilitate access to various imaging centers at USC including the new NIH funded 3T Research Resource located within the Department of Radiology at USC. The neuroimaging core has developed key technology in spatiotemporal fMRI and DTI tractography including normalization and quantificafion of tracts through white matter. During the past 5 years, the core supported 12 projects and pilots with the design of structural and functional imaging protocols including data acquisition, image processing and data analyses. The core also played a major role in successfully obtaining a High End Instrumentation grant from NCRR to establish a 3T research MRI facility at USC.

Public Health Relevance

Neuroimaging of the brain can offer early detection of Alzheimer and cerebrovascular disease. The Neuroimaging Core will assist Project 1 in differentiating different types of cognitive decline in elderly persons. It will assist Project 3 in determining whether decreased retinal blood flow can provide a screening tool for cerebrovascular disease.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Southern California
Los Angeles
United States
Zip Code
Kammen, Alexandra; Law, Meng; Tjan, Bosco S et al. (2016) Automated retinofugal visual pathway reconstruction with multi-shell HARDI and FOD-based analysis. Neuroimage 125:767-79
Soosman, Steffan K; Joseph-Mathurin, Nelly; Braskie, Meredith N et al. (2016) Widespread white matter and conduction defects in PSEN1-related spastic paraparesis. Neurobiol Aging 47:201-209
Barnes, Samuel R; Ng, Thomas S C; Montagne, Axel et al. (2016) Optimal acquisition and modeling parameters for accurate assessment of low Ktrans blood-brain barrier permeability using dynamic contrast-enhanced MRI. Magn Reson Med 75:1967-77
Forrester, Sarah N; Gallo, Joseph J; Smith, Gwenn S et al. (2016) Patterns of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Risk of Dementia. Am J Geriatr Psychiatry 24:117-25
Ebbert, Mark T W; Boehme, Kevin L; Wadsworth, Mark E et al. (2016) Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk. Alzheimers Dement 12:121-9
Kennedy, Richard E; Cutter, Gary R; Wang, Guoqiao et al. (2016) Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials. J Alzheimers Dis 50:1205-15
Crawford, Karen L; Neu, Scott C; Toga, Arthur W (2016) The Image and Data Archive at the Laboratory of Neuro Imaging. Neuroimage 124:1080-3
Finch, Caleb E; Shams, Sara (2016) Apolipoprotein E and Sex Bias in Cerebrovascular Aging of Men and Mice. Trends Neurosci 39:625-37
Halliday, Matthew R; Rege, Sanket V; Ma, Qingyi et al. (2016) Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease. J Cereb Blood Flow Metab 36:216-27
Bilousova, Tina; Miller, Carol A; Poon, Wayne W et al. (2016) Synaptic Amyloid-β Oligomers Precede p-Tau and Differentiate High Pathology Control Cases. Am J Pathol 186:185-98

Showing the most recent 10 out of 394 publications